Collaborative Research, Nov 2015

ImmunoSYS has developed a research project with the University of Sheffield and Phenix Group of Bangladesh on liquid biofuel from algae in Bangladesh. The project has received early stage funding from the BBSRC. Dr. Jim Gilmour of Sheffield University will be the scientific lead.

China-Britain SME Parrnership event in Manchester

ImmunoSYS met a number of companies from China at the China-UK SME event in Hilton, Manchester on 23 Oct. the event was organised jointly by the Bank of China and the UKTI on the occasion of the visit of the Chinese Prime Minister to the UK.

Welcome to ImmunoSYS



ImmunoSYS is an analytical service providing company specialising in immunologic and ultra-sensitive assays. We bring innovative solutions to biological analysis.

We have innovative and advanced systems that could help your work significantly.

The preclinical stage of drug development is a critical phase that takes a new investigational drug through efficacy and safety tests in non-human studies to the human studies in clinical phase. Assays that can be predictive of outcomes in human trials are of highest priority. ImmunoSYS is focused in developing and providing solutions in the immunology of drugs at this stage. Their innovative platform of comprehensive immunologic and pharmacokinetic analyses is a step towards understanding the safety of drugs before they are studied in humans. Go to link page here



ImmunoSYS is particularly focused in providing solutions in biotechnology dependent businesses. We help in building up capacity in biological systems that will help your business grow in agribusiness or biopharmaceuticals.

Go to link page here

What We Do


Our business is divided into four segments:

Biological capacity development

Analytical services (biomolecular)

Modelling of biological mechanisms


We work with organisations of all sizes including academic institutes, life science investors, start-up companies and established organisations. With help in establishing in-house research, tech transfer, building product portfolio, diversification strategy, industrial development and formulation of business plans.

ImmunoSYS is an R&D focused company. We work together with academia and biotech groups to develop innovative products and systems through research.

Our interest is focused on but not limited to the following sectors:

  • Biopharma
  • Agriculture
  • Medical and diagnostics
  • Academia and research industry



ImmunoSYS and Abundnz have joined forces and started a new company Immundnz Ltd ( that offers an innovative platform for the comprehensive immune analysis of drug molecules. Immundnz Ltd. is based at the BioHub at Alderley Park in Alderley Edge (UK).